AbogenBio

Suzhou, China · Founded 2019 · Privately Held (backing)

Developer of mRNA based therapeutics focused on advancing clinical stage RNA medicines with a mission to revolutionise the future of health and life. AbogenBio is based in Suzhou, China and was founded in 2019. Its last reported valuation was $3.7 billion in Nov 2021. It has raised $1.1 billion.

Last reported valuation

$3.7B

Oct 2026

Priced at

—

Total raised

$1.1B

Last round

—

How much has AbogenBio raised?

$1.1Bacross 0 recorded rounds

Free account

More of AbogenBio with a free account

·The complete investor list: 44 names
·Watch AbogenBio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

AbogenBio investors

44 investors are on record for AbogenBio, including Coatue Management, SoftBank Investment Advisers, Qiming Venture Partners and Temasek Holdings. By type, the record holds 8 venture capital firms and 2 private equity firms.

For fundraisers

Raising for a company like AbogenBio?

44 investors have backed AbogenBio.

See all 44 investors →

Frequently asked about AbogenBio

How much has AbogenBio raised?: AbogenBio has raised $1.1B in total across 0 recorded funding rounds.